Oncotelic Therapeutics, Inc. (OTLC) Finite-Lived Intangible Assets, Amortization Expense, Next Rolling Twelve Months

Oncotelic Therapeutics, Inc. Finite-Lived Intangible Assets, Amortization Expense, Next Rolling Twelve Months

Oncotelic Therapeutics, Inc. (OTLC) had Finite-Lived Intangible Assets, Amortization Expense, Next Rolling Twelve Months of $51.37 thousand as of 2019-12-31, per its 10-K filed 2020-05-14.

Discontinued › Notes › Intangible Asset, Finite-Lived, and Capitalized Cost, Software to be Sold, Leased, or Marketed, Estimated Amortization Expense › Intangible Asset, Finite-Lived, after Accumulated Amortization, Rolling Maturity

us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths · last filed 2020-05-14

• 2019-12-31: Finite-Lived Intangible Assets, Amortization Expense, Next Rolling Twelve Months $51.37K.
• 2019-09-30: Finite-Lived Intangible Assets, Amortization Expense, Next Rolling Twelve Months $51.37K.